Interestingly, the GRP94 and GRP78 protein levels and Edem2 and Herpud1 mRNA levels were also substantially reduced with PERK inhibition in the X-ALD fibroblasts following 48 h TM treatment (Fig. 4a, b). The gene discussed is HSPA5; the disease is X-linked adrenoleukodystrophy.